Wacker Chemie Ag · XETR:WCH
Wacker Chemie — Wacker Chemie Ag Ord — Q3 2025 Earnings Presentation
19 slides from Wacker Chemie's earnings presentation, Oct 30, 2025
Slide 1: Q3 2025 Earnings Call Note
Q3 2025 Earnings Call Note Wacker Chemie AG Dr. Christian Hartel (CEO), Dr. Tobias Ohler (CFO)
Slide 2: Disclaimer
Disclaimer The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on man
Slide 3: Q3 2025 Performance in Line With Market Expectations
Q3 2025 Performance in Line With Market Expectations Overview Financials Operations Sustainability Sales & EBITDA held back by weak Utilization rates remain unsatisfactory due to WACKER & Chem-X Initiative markets; cash flow supported by targeted ongoing macroeconomic & geopolitical actions to reduc
Slide 4: FY 2025 Outlook Refined & Cost Project Started
FY 2025 Outlook Refined & Cost Project Started Full year guidance and cost project Updated FY 2025 group outlook • Sales at the lower end of the €5.5 – 5.9bn range • EBITDA in the lower half of the €500 – 700m range • Net cash flow negative, substantially higher than PY Comprehensive cost project st
Slide 5: Q3 2025 EBITDA at €112m
Q3 2025 EBITDA at €112m Profit & loss Q3 2025 Q3 2024 Q3 comments Sales 1,340 1,430 • Sales -6% yoy Price -3%, FX -3%, Volume/Mix -1% Gross profit 154 213 • EBITDA -23% yoy Gross profit % 11.5% 14.9% • Performance held back by price, FX, volume/mix and unsatisfactory utilization rates EBITDA 112 145
Slide 6: Financials with €4.42bn in Equity and €781m in Liquidity
Financials with €4.42bn in Equity and €781m in Liquidity Balance sheet Assets Balance sheet per 09/30/25 Liabilities €9.4bn €8.6bn €9.4bn €8.6bn Cash & securities: • High level of liquidity at €781m 52% 54% 51% 52% Inventories: • - €173m lower YTD 11% 11% Pension provisions: 19% 19% 21% 23% • - €85m
Slide 7: Silicones: Weak Order Intake Continues in Q3
Silicones: Weak Order Intake Continues in Q3 Quarterly figures Sales (€m) Q3 Comments -7% • Volumes flat, mix weaker 727 650 745 713 673 • Sales & EBITDA held back by FX, price and mix • Q2 supported by insurance benefit Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITDA (€m) / margin FY 2025 Outlook (U
Slide 8: Polymers: EBITDA at PY Level
Polymers: EBITDA at PY Level Quarterly figures Sales (€m) Q3 Comments -6% • Sales held back by FX and price as well as lower volumes 365 360 363 344 in consumer-related dispersions yoy 337 • Construction remains soft Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITDA (€m) / margin FY 2025 Outlook (Updat
Slide 9: Biosolutions: Focus on Filling Capacities
Biosolutions: Focus on Filling Capacities Quarterly figures Sales (€m) Q3 Comments -7% • Sales and EBITDA driven by timing of customer project 100 106 recognition 91 87 93 • Q3 marked by soft demand environment Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITDA (€m) / margin FY 2025 Outlook (Update) 16
Slide 10: Polysilicon: Strong Semi Demand, Uncertainty in Solar
Polysilicon: Strong Semi Demand, Uncertainty in Solar Quarterly figures Sales (€m) Q3 Comments -6% • Strong semi demand, volumes sold significantly higher yoy 209 209 245 218 197 • New semi etching line on schedule • Low solar-grade demand, ASP lower qoq Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITD
Slide 11: Net Debt Increased to €1.16 Billion
Net Debt Increased to €1.16 Billion Year-to-date development of net debt 128 -691 -411 -124 -31 -27 -1,156 Net financial Cash flow from Cash flow from Dividend paid, Lease liabilities Fx, others Net financial debt debt 12.31.2024 operating activities investing before WACKER 09.30.2025 securities Wac
Slide 12: Q&A
Q&A
Slide 13: Silicone Innovations Enable High Performance Solutions
Appendix Silicone Innovations Enable High Performance Solutions K-Fair: Products presented at worlds largest plastics trade fair GENIOPLAST®® GENIOPLAST NEXIPAL® ELASTOSIL® eco ELASTOSIL® POWERSIL® Pellet 345 high performance smart laminates for sustainable innovative elastomers high performance Aso
Slide 14: Guidance FY 2025
Appendix Guidance FY 2025 Refined on October 30 In €m FY 2024 Outlook 2025 Sales 5,722 At the lower end of the €5.5 to 5.9bn range EBITDA1 744 In the lower half of the €500 to 700m range EBITDA margin (%)1 13.0 Substantially lower than prior year Net cash flow -326 Negative, but significantly better
Slide 15: Q3 Results
Appendix Q3 Results Year-over-year performance In €m Q3 2025 Q3 20241 % Sales 1,340 1,430 -6% EBITDA reported 112 145 -23% EBITDA-Margin 8.3% 10.2% - EBIT -20 30 - EBIT-Margin -1.5% 2.1% - Net income for the period -82 34 - EPS -1.73 0.56 - CapEx 111 149 -26% Net Cashflow 19 -99 - Net Financial debt
Slide 16: Segment Performance
Appendix Segment Performance 9M and Q3 results for the group and by segment In €m 9M 2025 9M 20241 Q3 2025 Q3 20241 Sales EBITDA % Sales EBITDA % Sales EBITDA % Sales EBITDA % Chemicals 3,199 418 13.1 3,282 432 13.2 1,017 134 13.1 1,092 152 13.9 SILICONES 2,132 294 13.8 2,156 272 12.6 673 86 12.8 72
Slide 17: Sustainability
Appendix Sustainability Progress towards ambitious group sustainability targets 2020 2021 2022 2023 2024 2030 Target Net Zero 100% 93% 87% 72% 76% 100% reduction by 2045 Value Up Sustainable products 83% 89% 90% 94% 94% 100% of products meet defined sustainability criteria Diversity: Women in manage
Slide 18: Raw Materials, Power and Gas
Appendix Raw Materials, Power and Gas Si-Metal (€/mt) Electricity (€/MWh) 10,000 500 8,000 400 6,000 300 4,000 200 2,000 100 0 0 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 VAM (€/mt) Natural Gas (€/MWh) 4,000 250 3,000 200 150 2,000 100 1,000 50 0 0 2021 2022 2023 2024 2025 2021 2022 2023 202
Slide 19: WACKER: Issuer, Contact and Additional Information
WACKER: Issuer, Contact and Additional Information Investor relations contacts Financial Calendar March 11, 2026 FY 2025 Results Joerg Hoffmann, CFA April 29, 2026 Q1 2026 Results Tel. +49 89 6279 1633 | joerg.hoffmann@wacker.com May 6, 2026 AGM Scott McCollister July 30, 2026 Q2 2026 Results Tel. +